217 related articles for article (PubMed ID: 26508204)
1. Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.
Akiyama M; Yamaoka M; Mikami-Terao Y; Ohyama W; Yokoi K; Arakawa Y; Takita J; Suzuki H; Yamada H
Int J Hematol; 2015 Dec; 102(6):723-8. PubMed ID: 26508204
[TBL] [Abstract][Full Text] [Related]
2. Constitutional abnormalities of IDH1 combined with secondary mutations predispose a patient with Maffucci syndrome to acute lymphoblastic leukemia.
Hirabayashi S; Seki M; Hasegawa D; Kato M; Hyakuna N; Shuo T; Kimura S; Yoshida K; Kataoka K; Fujii Y; Shiraishi Y; Chiba K; Tanaka H; Kiyokawa N; Miyano S; Ogawa S; Takita J; Manabe A
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28544751
[TBL] [Abstract][Full Text] [Related]
3. A Rare Co-Occurrence of Maffucci Syndrome and Astrocytoma with IDH1 R132H Mutation: A Case Report.
Ashirov N; Mammadinova I; Moldabekov A; Zhetpisbaev B; Teltayev D; Ryskeldiyev N; Akshulakov S
Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374260
[No Abstract] [Full Text] [Related]
4. Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome.
Hao S; Hong CS; Feng J; Yang C; Chittiboina P; Zhang J; Zhuang Z
J Neurosurg; 2016 Jun; 124(6):1562-7. PubMed ID: 26473790
[TBL] [Abstract][Full Text] [Related]
5. A case of Maffucci syndrome with a buccal hemangioma harboring a mutation in IDH1.
Ichimura N; Yamamoto N; Toyama N; Hibi H
Oral Oncol; 2021 Nov; 122():105553. PubMed ID: 34624834
[TBL] [Abstract][Full Text] [Related]
6. Maffucci syndrome and neoplasms: a case report and review of the literature.
Prokopchuk O; Andres S; Becker K; Holzapfel K; Hartmann D; Friess H
BMC Res Notes; 2016 Feb; 9():126. PubMed ID: 26920730
[TBL] [Abstract][Full Text] [Related]
7. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.
Pansuriya TC; van Eijk R; d'Adamo P; van Ruler MA; Kuijjer ML; Oosting J; Cleton-Jansen AM; van Oosterwijk JG; Verbeke SL; Meijer D; van Wezel T; Nord KH; Sangiorgi L; Toker B; Liegl-Atzwanger B; San-Julian M; Sciot R; Limaye N; Kindblom LG; Daugaard S; Godfraind C; Boon LM; Vikkula M; Kurek KC; Szuhai K; French PJ; Bovée JV
Nat Genet; 2011 Nov; 43(12):1256-61. PubMed ID: 22057234
[TBL] [Abstract][Full Text] [Related]
8. Cell-free DNA from plasma as a promising alternative for detection of gene mutations in patients with Maffucci syndrome.
Sun Y; Fan X; Rao Y; Wang Z; Wang D; Yang X; Zheng L; Wen M; Cai R; Su L
Hereditas; 2022 Jan; 159(1):4. PubMed ID: 35042566
[TBL] [Abstract][Full Text] [Related]
9. Maffucci syndrome complicated by three different central nervous system tumors sharing an IDH1 R132C mutation: case report.
Nejo T; Tanaka S; Ikemura M; Nomura M; Takayanagi S; Shin M; Ushiku T; Shibahara J; Saito N; Mukasa A
J Neurosurg; 2018 Dec; 131(6):1829-1834. PubMed ID: 30579273
[TBL] [Abstract][Full Text] [Related]
10. IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation.
Yamaguchi S; Iwanaga E; Tokunaga K; Nanri T; Shimomura T; Suzushima H; Mitsuya H; Asou N
Eur J Haematol; 2014 Jun; 92(6):471-7. PubMed ID: 24443894
[TBL] [Abstract][Full Text] [Related]
11. IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome.
Moriya K; Kaneko MK; Liu X; Hosaka M; Fujishima F; Sakuma J; Ogasawara S; Watanabe M; Sasahara Y; Kure S; Kato Y
Cancer Sci; 2014 Mar; 105(3):359-62. PubMed ID: 24344754
[TBL] [Abstract][Full Text] [Related]
12. Somatic
Brown NJ; Ye Z; Stutterd C; Jayasinghe SI; Schneider A; Mullen S; Mandelstam SA; Hildebrand MS
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34588213
[TBL] [Abstract][Full Text] [Related]
13. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.
Amary MF; Damato S; Halai D; Eskandarpour M; Berisha F; Bonar F; McCarthy S; Fantin VR; Straley KS; Lobo S; Aston W; Green CL; Gale RE; Tirabosco R; Futreal A; Campbell P; Presneau N; Flanagan AM
Nat Genet; 2011 Nov; 43(12):1262-5. PubMed ID: 22057236
[TBL] [Abstract][Full Text] [Related]
14. IDH1-R132 changes vary according to NPM1 and other mutations status in AML.
Falini B; Spinelli O; Meggendorfer M; Martelli MP; Bigerna B; Ascani S; Stein H; Rambaldi A; Haferlach T
Leukemia; 2019 Apr; 33(4):1043-1047. PubMed ID: 30622284
[No Abstract] [Full Text] [Related]
15. Maffucci syndrome complicated by giant chondrosarcoma in the left ankle with an IDH1 R132C mutation: a case report.
Lv H; Jiang H; Zhang M; Luo H; Hong Z; Yang H; Xu W; Shen B; Zhang W; Qiu H; Zhu R
World J Surg Oncol; 2022 Jun; 20(1):218. PubMed ID: 35765075
[TBL] [Abstract][Full Text] [Related]
16. IDH1 R132C and ERC2 L309I Mutations Contribute to the Development of Maffucci's Syndrome.
Cheng P; Chen K; Zhang S; Mu KT; Liang S; Zhang Y
Front Endocrinol (Lausanne); 2021; 12():763349. PubMed ID: 34790172
[TBL] [Abstract][Full Text] [Related]
17. IDH1 immunohistochemistry reactivity and mosaic IDH1 or IDH2 somatic mutations in pediatric sporadic enchondroma and enchondromatosis.
Saiji E; Pause FG; Lascombes P; Cerato Biderbost C; Marq NL; Berczy M; Merlini L; Rougemont AL
Virchows Arch; 2019 Nov; 475(5):625-636. PubMed ID: 31240473
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].
Wei H; Zhang YQ; Lin D; Wang Y; Zhou CL; Liu BC; Li W; Rao Q; Wang M; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):11-5. PubMed ID: 24598642
[TBL] [Abstract][Full Text] [Related]
19. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.
Amary MF; Bacsi K; Maggiani F; Damato S; Halai D; Berisha F; Pollock R; O'Donnell P; Grigoriadis A; Diss T; Eskandarpour M; Presneau N; Hogendoorn PC; Futreal A; Tirabosco R; Flanagan AM
J Pathol; 2011 Jul; 224(3):334-43. PubMed ID: 21598255
[TBL] [Abstract][Full Text] [Related]
20. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
